Physician profile
David A Sanchez
NPI 1962859777
$5,539.02
in general payments reported to CMS, 2019-2025
29 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $1,049 · 2021: $2,371 · 2022: $506 · 2023: $396 · 2024: $278 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,580.37 | 2019-2022 | |
| Wright Medical Technology, INC. | $820.72 | 2020 | |
| Stryker Corporation | $692.03 | 2019-2021 | |
| Treace Medical Concepts, INC. | $427.15 | 2021-2025 | |
| Smith+Nephew, INC. | $424.33 | 2019-2025 | Grafix Pl, Grafix, Stravix Pl |
| Paratek Pharmaceuticals, INC. | $192.60 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $185.90 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $148.63 | 2019-2023 | Fibulink |
| Organogenesis INC. | $128.86 | 2020-2022 | |
| Abbott Laboratories | $124.62 | 2022 | |
| Titan Surgical Group, LLC | $100.06 | 2022 | |
| Medtronic, INC. | $83.91 | 2022-2025 | Intellis Adaptivestim |
| Abbvie INC. | $68.75 | 2021-2024 | |
| Heron Therapeutics, INC. | $60.46 | 2021-2024 | Zynrelef |
| Convatec INC. | $54.06 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $48.25 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $47.75 | 2023 | Krystexxa |
| Nevro Corp. | $45.91 | 2023-2024 | Senza |
| Janssen Pharmaceuticals, INC | $43.08 | 2021-2022 | |
| Melinta Therapeutics, LLC | $42.92 | 2019-2020 | |
| Avita Medical Americas, LLC | $32.39 | 2024 | |
| Baudax Bio INC. | $31.24 | 2020 | |
| Globus Medical, INC. | $29.68 | 2025 | Senza |
| Reprise Biomedical, INC. | $26.46 | 2025 | Miro3d |
| Polynovo North America LLC | $26.04 | 2024 | Novosorb Btm |
| Acumed LLC | $23.09 | 2024 | Acumed, Osteomed |
| Bioventus LLC | $19.17 | 2024 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $17.99 | 2025 | |
| Merck Sharp & Dohme LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.